Thomas Velenosi, University of British Columbia

Research

Biomarkers Polyamines Triple Negative Breast Cancer Metabolomics Triple-Negative Breast Cancer Patient-Derived Xenograft Diacetylspermine Patient-Derived Xenografts

Latest funding

Characterizing diacetylspermine as a biomarker of drug response and precision treatment in triple-negative breast cancer
CIHR · 2024 · Nominated PI
$979,200
Development and evaluation of novel nanoparticle formulations for therapeutic genome editing
CIHR · 2023 · Co-investigator
$975,376
Characterizing diacetylspermine as a biomarker of drug response and precision treatment in triple-negative breast cancer
CIHR · 2023 · Nominated PI
$100,000

All 5 grants and awards

Characterizing diacetylspermine as a biomarker of drug response and precision treatment in triple-negative breast cancer

Nominated PICIHR2024Project Grant

Principal investigators: Velenosi, Thomas J

Keywords: Biomarkers; Metabolomics; Polyamines; Triple-Negative Breast Cancer

$979,200

Development and evaluation of novel nanoparticle formulations for therapeutic genome editing

Co-investigatorCIHR2023Project Grant

Principal investigators: Ross, Colin J; Blakney, Anna

Keywords: Animal Models; Base Editor; Gene Editing; Genetic Disease; Lipid Nanoparticle; Nanoparticle; Prime Editor

$975,376

Characterizing diacetylspermine as a biomarker of drug response and precision treatment in triple-negative breast cancer

Nominated PICIHR2023Project Grant - PA: Breast Cancer Research

Principal investigators: Velenosi, Thomas J

Keywords: Biomarkers; Patient-Derived Xenograft; Polyamines; Triple Negative Breast Cancer

$100,000

Characterizing and validating diacetylspermine as a metabolic biomarker of drug response and precision treatment in triple-negative breast cancer

Nominated PICIHR2022Project Grant - PA: Breast Cancer Research

Principal investigators: Velenosi, Thomas J

Keywords: Biomarkers; Diacetylspermine; Patient-Derived Xenografts; Polaymines; Spermine/Spermidine N1-Acetyltransferase 1; Triple Negative Breast Cancer

$100,000

Development and evaluation of novel nanoparticle formulations for therapeutic genome editing

Co-investigatorCIHR2022Project Grant

Principal investigators: Ross, Colin J; Blakney, Anna

Keywords: Animal Models; Base Editor; Gene Editing; Genetic Disease; Lipid Nanoparticle; Nanoparticle; Prime Editor

$100,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2024

Subject: Prospective PhD student: Biomarkers Dear Professor Velenosi, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on biomarkers connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Characterizing diacetylspermine as a biomarker of drug response and precision treatment in triple-negative breast cancer" (2024), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]